title: Lack in treatment options for virus-induced inflammatory cardiomyopathy: can iPS-derived cardiomyocytes close the gap?
authors.affiliation: From the Berlin-Brandenburg Center for Regenerative Therapies, Charité, University Medicine Berlin, Campus Virchow Clinic, Berlin, Germany (S.V.L., C.T.); and Department of Cardiology and Pneumology, Charité, University Medicine Berlin, Campus Benjamin Franklin, Berlin, Germany (H.-P.S., C.T.).
authors.forename: Sophie
authors.initials: S
authors.lastname: Van Linthout
authors.affiliation: From the Berlin-Brandenburg Center for Regenerative Therapies, Charité, University Medicine Berlin, Campus Virchow Clinic, Berlin, Germany (S.V.L., C.T.); and Department of Cardiology and Pneumology, Charité, University Medicine Berlin, Campus Benjamin Franklin, Berlin, Germany (H.-P.S., C.T.).
authors.forename: Carsten
authors.initials: C
authors.lastname: Tschöpe
authors.affiliation: From the Berlin-Brandenburg Center for Regenerative Therapies, Charité, University Medicine Berlin, Campus Virchow Clinic, Berlin, Germany (S.V.L., C.T.); and Department of Cardiology and Pneumology, Charité, University Medicine Berlin, Campus Benjamin Franklin, Berlin, Germany (H.-P.S., C.T.). Heinz-Peter.Schultheiss@charite.de.
authors.forename: Heinz-Peter
authors.initials: HP
authors.lastname: Schultheiss
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D029822:Enterovirus B, Human / Q000302:isolation & purification*; D004769:Enterovirus Infections / Q000188:drug therapy*; D006801:Humans; D008955:Models, Cardiovascular; D009205:Myocarditis / Q000188:drug therapy*; D032383:Myocytes, Cardiac / Q000473:pathology*; D039904:Pluripotent Stem Cells / Q000473:pathology*
chemical_list: D000998:Antiviral Agents
keywords: drug evaluation, preclinical; myocytes, cardiac